Updated: May 19, 2026

Paul Varki

AVTXAvalo Therapeutics, Inc.SEC CIK: 0001677896
Estimated Net Worth
$656 Thousand
Last Updated: May 19, 2026 11:43 PM EST

Transaction Summary

Total Transactions13
Buy-Sell Ratio0.00
Buy Transactions0
Sell Transactions5

Transaction Volume

Total Volume-$591.60K
Net Volume$591.60K
Buy Volume$0.00
Sell Volume-$591.60K

Trade Analysis

AVG Trade Size-$45.83K
Largest Trade$0.00
Most Active MonthJun
Most Active Year2017

Trading Sentiment

OverallBullish
Recent TradeSelling
Last 90 Days-1 Trades
ConvictionMedium

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Paul Varki does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Egalet Corp, and Avalo Therapeutics, Inc..



2026 was Paul Varki's most active year for acquiring shares with 3 total transactions. Paul Varki's most active month to acquire stocks was the month of April. 2026 was Paul Varki's most active year for disposing of shares, totalling 7 transactions. Paul Varki's most active month to dispose stocks was the month of April. 2026 saw Paul Varki paying a total of $940,381.52 for 155,063 shares, this is the most they've acquired in one year. In 2026 Paul Varki cashed out on 150,126 shares for a total of $1,513,673.14, their largest year based on trade value.

Holdings & Transactions

AVTXavalo therapeutics, inc.
Chief Legal Officer
Updated: May 07, 2026VIEW QUOTE
Form TypeSEC Filing
-0.3075.06K$16.35-$573.29K178.57KScheduledMay 06View
80.00K80.00KFeb 26View
-0.221.02K$4.10-$4.17K3.63KDec 10View
100.00K100.00KJan 28View
150.00K150.00KJun 24View
View
egalet corp
SVP, GC & Chief Compliance Off Officer
Updated: Jul 06, 2017
Form TypeSEC Filing
-0.03806.00$2.35-$1.89K29.51KScheduledJul 03View
50.00K50.00KJun 08View
-0.03806.00$5.05-$4.07K28.82KScheduledApr 03View
-0.03806.00$7.75-$6.25K29.63KScheduledJan 03View
50.00K50.00KDec 06View
-0.03806.00$7.56-$6.09K30.43KScheduledOct 03View
31.24KView